A Phase 2 Study with Volasertib for Ven-HMA Relapsed/Refractory Acute Myeloid Leukemia Patients Guided By a Predictive Precision Medicine Platform Wagner, J., Lacher, M. D., Gu, C. J., Leonardi, C., Mannis, G. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-186953

View details for Web of Science ID 001159900803238